Daniel Matlow, President & CEO

TSXV VHI

CONFIDENTIAL • NOT FOR REDISTRIBUTION • MARCH 2018 TSXV VHI

Reader’s Advisory (1 of 2)
This corporate presentation dated October 2017 (the “Presentation”) has been prepared by management of Vitalhub Corp. (the “Corporation”), and is
based on public information and the Corporation’s confidential information. This Presentation is for information purposes only and is being made
available on a confidential basis solely to enable the prospective “accredited” and other qualified investors authorized by the Corporation to evaluate
the securities of the Corporation (the “Securities”). This Presentation does not constitute an offer to sell to any person, or a general offer to the public
of, or the general solicitation from the public of offers to subscribe or purchase, any of the Securities. Any unauthorized use of this Presentation is
strictly prohibited. Distribution or copying of this Presentation, in whole or in part in any medium, to any person other than the prospective investor is
prohibited without the prior written consent of the Corporation. The information contained in these slides, the Presentation made to you verbally and
any other information provided to you (in writing or otherwise) in connection with the Corporation and its business (the “Presentation Materials”) is
subject to updating, completion, revision, verification and amendment without notice which may result in material changes. The Presentation
Materials are not intended to provide financial, tax, legal or accounting advice and do not purport to contain all the information that a prospective
investor may require. Each prospective investor should perform and rely on its own investigation and analysis of the Corporation and the terms of any
offering of the Securities, including the merits and risks involved, and are advised to seek their own professional advice on the legal, financial and
taxation consequences of making an investment in the Corporation. The Securities are highly speculative.

No securities commission or similar regulatory authority in Canada has reviewed or in any way passed upon the Presentation Materials, and any
representation to the contrary is an offence. Neither the Corporation nor any agent of the Corporation makes any representation or warranty,
express or implied, and assumes no responsibility for the accuracy or completeness of the information contained in the Presentation Materials or any
other oral or written communication transmitted to prospective investors, and nothing contained in this summary is, or shall be relied upon as, a
promise or representation by the Corporation or any agent of the Corporation as to the past or future performance of the Corporation. The
Corporation does not undertake to provide any additional further information or to enter into negotiations regarding the investment opportunity to
which these Presentation Materials relate. The Corporation retains the right, at any time, to terminate any discussions or negotiations with
prospective investors. In the event of such termination the Corporation will not be under any obligation to disclose the reasons for such termination
nor will they have any liability to any recipient hereof for any costs whatsoever incurred in the consideration of the information contained in these
Presentation Materials.

2 TSX.V V H I
Reader’s Advisory (2 of 2)
This presentation contains forward-looking statements. Often, but not always, forward-looking statements can be identified by the use of words such
as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or “recurring” or
variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be
achieved. Forward looking statements contained in this Presentation may include, but are not limited to statements with respect to the successful
execution of the Corporation's business strategy (including its business model. M&A strategy and mission), the use and benefits of its products and
services, the Corporation’s favourable position in the market on a go-forward basis, demographic and market size/trends, forecasts of revenue and
financial projections/growth potential/opportunities, the completion of proposed acquisitions of target companies, the use of proceeds from the sale
of the Corporation’s Securities, competitive analysis, proposed synergies, projected milestones, go-forward management of the Corporation, and
other expectations, beliefs, plans, objectives, assumptions, intentions or statements about future events or performance, expected regulatory filings,
review and approval dates, construction and start-up timelines and schedules, and statements related to the continued overall advancement of the
Corporation’s projects. Forward-looking statements involve known and unknown risks, uncertainties and other factors, such as competition,
technological changes, the changing needs of hospitals, the financial condition of Vitalhub’s current and potential customers, foreign currency
exchange rates, as well as general economic conditions, which may cause the actual results, performance or achievements of Vitalhub to be materially
different from any future results, performance or achievements expressed or implied by the forward-looking statements. Actual results and
developments are likely to differ, and may differ materially, from those expressed or implied by the forward-looking statements contained in this
presentation.

There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from
those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The forward looking
statements contained in this presentation are made as of the date hereof or the dates specifically referenced in this presentation, where applicable.
Except as required by law, the Corporation undertakes no obligation to update publicly or to revise any forward looking statements that are contained
or incorporated in this presentation. All forward looking statements contained in this presentation are expressly qualified by this cautionary statement.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this presentation.

3 TSX.V V H I
VitalHub Inc. – Company Overview

• High-growth strategy through the introduction of Blockchain Healthcare Solutions using the
Hyperledger Platform, combined with a reliable/profitable M&A “hedge” strategy
• New RTO completed in December 2016 (ticker VHI.V)
• SaaS-based, high-margin products that can be sold organically across the digital health
marketplace, and cross-sold into acquired-companies’ install bases
• Management team and Board of Directors with proven success operating a publicly traded,
Canadian-based Healthcare IT company
• Offshore research and development (“R&D”) strategy that cuts costs, increases margins, and
produces synergized businesses and products offerings

4 TSX.V V H I
VitalHub Inc. – Company Principals
Dan Matlow
(CEO and Founder, Medworxx)
• 30 years experience in technology field with focus
on Health IT
• Track record of building and growing enterprise
software companies
• Strong sales, marketing, and investor relations skills
• Proven ability to grow internationally
• Deep knowledge of the Healthcare IT marketplace
Vijit Coomera
(Co-Founder and CTO, B Sharp)
• 30 years experience in development and tech
• Extremely technically savvy, developing innovative
and disruptive technology solutions
• Managed technological and architectural software
dev. of multiple projects across N.A. and Europe
• Oversaw establishment of dev. hub in Sri Lanka
Peter Catford
(Co-Founder and CEO of HInext Inc.)
• 30+ of experience in healthcare information
systems development
• Developed EHR software system installed in
85 organizations across N.A.
• Adjunct Faculty UofT; informatics in the
Masters of Health Admin program (MHSc)
• Past Chair of Ontario’s Health Informatics
Standards Council (OHISC)

Brian Goffenberg CA, CPA
(CFO, Medworxx)
• 30 years experience, multiple CFO
roles including Philips Lifeline
(Canada), DWL, etc.
• Strong public market experience
• Proven results-driven track record
• Extensive financial governance
skills and experience
Robert Lazar
(Co-Founder & CEO, B Sharp)
• 28 years experience
• Expertise driving company performance
through post-sales management
• Proven track record building both client
and business partnership relationships
• IT consulting for $6B distributor and
retailer
Niels Tofting
(VP Sales, Logibec)
• 20 years of software experience
• Developed and managed high-
performing sales teams Success
supporting diverse vertical markets
• Experience leading international
business development and growth
Andre Vandenberk
(CTO, Medworxx)
• Deep understanding of Healthcare IT
• Technology visionary
• 20 years experience in Product
Development
• Strong ability to communicate
business value to an IT audience

5 TSX.V V H I
Medworxx History

• International Healthcare IT company that was publicly traded on the TSX.V

• Unique Patient Flow solutions originating from use at Canadian hospitals
• Solutions are used by over 70% of hospitals across Canada
• Grew internationally to over $8 million in revenue across five countries
• Share price grew from 5 cents in 2008 to 60 cents in 2015 (CAGR 30% beds under license)
• Sold to Aptean, a subsidiary of Vista Equity Partners, in October 2015 for a valuation
of $20 million

6 TSX.V V H I
VitalHub Inc. – Board of Directors
Dan Matlow
• President and CEO Vitalhub Inc.
• 30 years experience
• Former Founder and CEO of Medworxx Inc.
Proven Healthcare IT executive
• Strong sales, marketing, and investor
relations skills
• Proven ability to grow internationally
Roger Dent
• Chief Executive and Director of
Quinsam Capital Corporation
• Director of Acuity Ads Holdings Inc.
• Former Portfolio Manager with Matrix
Fund Management
• Former Director of research for CIBC
World Markets
7 TSX.V V H I
Mohan Plakkot
• Partner and Chief Strategist at Valsef Capital, a
private investment company focusing on public
software companies
• Experience in fortune 500 financial software
and services company
• MBA in Strategy and Finance, with experience
in structuring M&A transactions for internet
assets
Barry Tissenbaum
• Retired fmr. Senior Partner with Ernst & Young
• Currently serves on the Noranda Income Fund
Board, and is Chairman of the Audit Committee
• Served on boards of many private and public
companies providing strategic accounting
governance
Chris Schnarr
• Managing Director of Lorian Group Inc.
• 25 years public company and board experience
across a range of roles and industries
• Currently Director, Chair of the Audit
Committee, and member of the Governance
and Compensation Committees of Canopy
Growth Corporation and Intrinsic 4D Inc.
Steve Garrington
• Former Director of 3 public companies listed
on Canadian, Australian, and UK exchanges
• Executive Vice President InterSystems Inc.
• 30 years of Healthcare IT Experience with
a vast amount of International experience
VitalHub Timeline

2014 2016 2017 JAN 2018 CURRENT

VitalHub grew out Purchased by key former Acquired B-Sharp Acquired H.I. Next Introduction of
of a collaboration members of the Technologies, 24- Inc., large US install Healthcare Blockchain
between Mount Medworxx management person offshore base, As of Jan 2018 solutions, built on the
Sinai Hospital in team in May of 2016 development team, it has since been Hyperledger Platform
Toronto and MaRS currently generating generating CAD 3.1M
Innovation Closing of qualifying CAD $1.4M in in annual revenue,
transaction and recurring revenue $2.4M in recurring
public offering revenue

8 TSX.V V H I
 The digital healthcare marketplace has
Blockchain Solutions experienced transformative growth over
to Healthcare the past 15 years, redefining the delivery
of care. This comes with extreme
Challenges pressure to regulate costs while
providing high-quality care to patients.

The problem is that growing Blockchain applications can benefit the

demand for healthcare services and healthcare ecosystem as a whole,
integrated-care delivery creates an alleviating several major challenges to the
unaddressed need for information industry; supporting seamless information
technology solutions that remove sharing that can eliminate the duplication,
middlemen, reduce costs, and errors and inconsistencies that arise with
promote privacy and security. traditional, centralized data storage.

9 (Source: Dash, Majumdar, and Gunjikar, “Blockchain: A Healthcare Industry View”, Capgemini 2017.) TSX.V V H I
Blockchain Technology for Healthcare Industry

M&A – Buying Assessment-

Based Assets Explosive
Growth
Blockchain – Future
Healthcare Solutions Expectation:
$1M+ Projects
LEGEND
Phase I: Proof of Concept/ Early
Pilot Projects Profitability
Phase II: Production Use
Phase III: Full-Scale Production
($1M+ Gov’t & Int’l Projects)

10 TSX.V V H I
Healthcare – Explosive Blockchain Opportunity

Barriers limiting the effective Siloed Healthcare Unlocking Siloed Healthcare

use and accessibility of siloed Information Information Securely with a
healthcare databases Decentralized Encrypted Ledger

11 TSX.V V H I
Validation – Blockchain Technology in Healthcare

“Blockchain solutions for financial services have received the maximum investments.
Healthcare has the most aggressive plans to deploy Blockchain-based applications across
multiple use cases during 2017.” (Source: "Blockchain Technology in Global Healthcare, 2017–2025", Frost & Sullivan, June 2017.)

“Blockchain technologies hold the promise to unite the disparate processes in healthcare,
increase data flow and liquidity, reduce costs, and improve patient experience and
outcomes.” (Source: “The Potential for Blockchain Technology in Health IT”, HIMSS, March 1 2017)

“[…] We believe Blockchain has a huge potential to become the next big technology-
innovation engine. Blockchain applications for patient-data portability, interoperability, care-
delivery management, and administration can provide the answers to make challenges facing
the industry.” (Source: “Blockchain: A Healthcare Industry View”, (Source: Dash, Majumdar, and Gunjikar,
“Blockchain: A Healthcare Industry View”, Capgemini 2017.)

12 TSX.V V H I
Blockchain Technology for Healthcare Industry
Top 5 Growth Opportunities by Use-Case, Global, 2016–2025
Use Cases

Healthcare Data Exchange Claims Adjudication & Drug Supply Chain Integrity Clinical Trails and Population Cyber Security and Internet
and Interoperability Billing Management and Remote Auditing Health Research of Medical Things (IoMT)

Provide access to historic and
real-time patient data on
Blockchain
Identity management with
Key Benefits
New product venture like DAO- Drug supply chain provenance at Manage IP and assets transactions Encryption and permanent ledger
based peer-to-peer insurance individual product/drug level on Blockchain of patient-generated health data
Decentralized Blockchain-based remote Reduce outcome switching, data Medical device data integration
marketplace processes auditing with verifiable snooping, and selective reporting and security to enable

predefined user access rules for source of truth remote/home care

P2P networking
Store genomics and user-
generated data securely, with
access control
Maintain universal health
records and identities
Impact*
Automate underwriting
and policy insurance
Improve claimant and
beneficiary KYC
Automate claim processing
Reduce admin costs
Improve pharma supply
chain finance
More visibility for marketing
efforts and medication
adherence programs
Better and faster regulatory
compliance and approvals Unique identifiers for medical
devices or assets on Blockchain
Bilateral interactions and
shared ledger system to automate
communication with all industry
maintenance and management
participants

$18.5 B $97.5 B $200 B $25.5 B $5.2 B

*Impact: Indicates the potential cost saving opportunities with successful deployment of Blockchain across these 5 use cases globally.

13 (Source: "Blockchain Technology in Global Healthcare, 2017–2025", Frost & Sullivan, June 2017.) TSX.V V H I
Use Case 1 – Healthcare Data Exchange & Interoperability

At its core, Blockchain would offer the potential of a shared platform that decentralizes health data
ensuring access control, authenticity, and integrity of protected health information.

Interoperability Gaps: Lack of interoperability costs 150,000 lives and $18.6 billion per year.
Challenges
Current

Need for Longitudinal Health Records: 46% of US clinicians do not have a complete view of their patients’
health history/ records. Further, individuals cannot view a unified medical record or pass it on to clinicians.
High Error Rates with Centralized Health IT Systems: Error rates for successfully identification or integration of
a file are 25% for hospitals and health systems; and as high as 50%–60% outside hospitals.

Key Blockchain Features

Access to historic and real-time patient data on Blockchain, cryptographically secure
and irrevocable or immutable.
Identity management with predefined user access rules peer-to-peer network;
multi-party collaboration health bank for remunerative commons.
Storage of genomics and user- generated data securely with access control.

14 (Source: "Blockchain Technology in Global Healthcare, 2017–2025", Frost & Sullivan, June 2017.) TSX.V V H I
Use Case 1 – Healthcare Data Exchange & Interoperability

(i) Blockchain-enabled health IT systems that can provide technological solutions to many
challenges, including health data interoperability, integrity and security, portable user-
owned data and other areas.

(ii) Blockchain could enable data exchange systems that are cryptographically secured and
irrevocable, enabling seamless access to historic and real-time patient data, while
eliminating the burden and cost of data reconciliation.

(iii) The recent collaboration between Guardtime, the data-centric

security company, and the Estonian eHealth Foundation to
secure the health records of one million Estonian citizens
using its proprietary Keyless Signature Infrastructure (KSI)
is a classic example of Blockchain technology.

15 (Source: "Does Blockchain Have A Place In Healthcare?" Forbes, www.forbes.com, May 8, 2017.) TSX.V V H I
Distribution Strategy

System Integrators
Vendors/Consulting Partners
Direct Sales
Management team has successfully
sold internationally through system
integrators, and has proven large
project implementation skills.

VitalHub’s entire platform is being built

on Hyperledger Technology Set.

16 TSX.V V H I
Blockchain Pricing Strategy

Recurring Revenue Stream

$ • BaaS-based, long-term annual-use Blockchain as a Service (BaaS)
contracts (i.e. 5-years)
• Annual fees based on usage and
amount of data
• High-margin products
Expectation:
Blockchain projects
will be large in nature

$
One Time Consulting Fees Large government and
• One-time and ongoing international projects
(large in nature)
• Implementation and Training
• Best practice and advisory
consulting fees
17 TSX.V V H I
M&A Strategy
VitalHub’s strategy is to rapidly increase growth and profitability by combining like software
companies focused in the Healthcare IT area

Global mHealth market

projection 22% CAGR

Reduce R&D Spend Consolidate G&A Optimize S&M Cross-Selling Products Build Mobile Solutions Sell Organically
Reduction of R&D Consolidation of Implementation Upselling VitalHub Create mobile versions Develop and sell
costs by moving dev finance and of effective sales mHealth platform of legacy apps mobile new VitalHub
offshore with a administration and marketing into install base and upsell into existing products into large
significantly reduced into a central processes install bases growth markets
wage structure functional area

18 TSX.V V H I
M&A Strategy

Have identified 15 companies Target companies are synergistic with annual

Combination of cash and stock
revenues of $1M-$7M, profitable with limited
primarily in Canada, UK and Australia using the public markets
growth, and have not adopted a mobile strategy
that are looking for exits

20% 20%-30% 1.0-2.5x

Reduce costs by 20% through Target 20%-30% EBITDA with cross-selling Purchase companies between
synergistic reductions and utilization and synergistic cost reductions including 1.0x-2.5x revenue multiple
of cost effective offshore resources effective offshore development work

19 VitalHub mHealth solution will be sold to target install bases TSX.V V H I

Target Companies – Acquisition Characteristics
Target Companies possess these qualities
• Recurring revenue above 60% of total revenue
• Breakeven or profitable
• Owner operated businesses with limited outside investment
• Large component of expense is on research and
development vs. sales and marketing
• Little commercialization or sales and marketing expertise
• Significant customer base with minimal retention issues
• Limited or no expansion beyond geographical boundaries
creating a large growth barrier
• Ability to upsell to existing install bases of target companies
by bringing their product into a mobile environment

20 TSX.V V H I
VitalHub – Acquisition #1
1. Mobile health enterprise software
solutions vendor
2. Current revenues of $560k
per annum
3. $490k annual recurring revenue
21
4. Over $7M invested in R&D since inception
5. Roots within MaRS and Mount Sinai
hospital in Toronto
6. Recent Sales and Marketing initiatives
driving growing pipeline
TSX.V V H I
VitalHub – The Integrated Mobility Solution

VitalHub acts as a bridge, aggregating, consolidating, and

porting data from siloed legacy health systems into an easy
to use mobile format.

VitalHub is an innovative solution that provides hospitals and

vendors with an enabling technology that integrates and
optimizes information across existing digital health systems.

Strong mobility IP allows the data of siloed legacy health

systems to be made easily available for mobile consumption,
simplifying availability and access for clinicians.

22 TSX.V V H I
 VitalHub’s mHealth Solution
VH Chart
Real-time patient
information at the
point of need on any
mobile device
VH Engage
Communication tools
enabling hospitals to
interact with patients
and families
VH Family Portal
Providing family members
with real-time information on
the health and mental status
of their loved ones
23
VH Physician Onboarding
Communicate with all your
physicians using mobile
devices for easy physician
onboard and ongoing
VitalHub packages information target communication
and data, making it more
accessible for mobile use
VH Task Manager
Assign, schedule
and monitor employee
tasks in all healthcare
settings using
mobile devices
TSX.V V H I
Acquisition #2: B Sharp Technologies (Oct 2017)
• 20 year old Canadian company
• $2.3 million (CAD) annual revenue 40 Canadian
• $1.5 million (CAD) recurring revenue Hospital
• CEO and CTO possess strong app Customers
development and operational skills
and will join management team
• Domain and healthcare development expertise

Five Products with an Emphasis on Mental Health

• Cardiac Electronic Health Records
• Mental Health EHR solution
• Long term Care EHR solution
• Pharmacy Solution
• AIDS EHR
Source: Information provided by B Sharp Technologies and has not been independently verified by the Corporation.
The Corporation or its agents undertake no obligation to comment on analysis, expectations or statements made by
24 third parties in relation to B Sharp Technologies, its security or their respective financial or operating results. TSX.V V H I
B Sharp Technologies: Offshore Development Team

Twenty-four member offshore development team Colombo, Sri Lanka

located in Sri Lanka

Strong offshore base to develop and

grow Blockchain solutions

Characteristics
• In operation since 2008
• Team of 24 developers
• Average salary of $18k (CAD) per year
• Average tenure of 4 years
• Total cost of operation is $600k (CAD) per year 24 Member Offshore
Development Team
Source: Information provided by B Sharp Technologies and has not been independently verified by the Corporation.
The Corporation or its agents undertake no obligation to comment on analysis, expectations or statements made by
25 third parties in relation to B Sharp Technologies, its security or their respective financial or operating results. TSX.V V H I
Acquisition #3: H.I. Next Inc. (Jan 2018)
• 19 year old company with large U.S. install U.S. business primary growth area
• 80 Behavioral Health Institution Customers
• $3.1 million (CAD) annual revenue
• $2.4 million (CAD) recurring revenue
• Mental Health EHR sold both in Canada and the U.S.
• CEO is the former CIO of CAMH with large
knowledge base especially in the mental health area
• Strong U.S. partner driving sales
• Opportunity to significantly lower R&D costs
• Mental health and clinical domain expertise 40 U.S. Behavioral Health
Source: Information provided by H.I. Next Inc., and has not been independently verified by the
Corporation. The Corporation or its agents undertake no obligation to comment on analysis, expectations
Institution Customers
or statements made by third parties in relation to H.I. Next Inc., its security or their respective financial or
operating results.
+40 in Canada

26 TSX.V V H I
M&A Synergies Result in EBITDA Growth

Upsell VitalHub
Mobility Solution to
Target Companies’
Install Bases
27 TSX.V V H I
Estimated Capital Structure Post M&A

Shares %
Current Shareholding 124,885,709 100.0%
Public 78,835,166 61.5%
Management control 48,050,543 38.5%

Total 124,885,709 100.0%

Approximately 21% of the public float is held by institutions.

28 TSX.V V H I
Post M&A – Estimated P&L (Pre-Blockchain)
% Revenue % OPEX % Revenue $

Revenue $ 6,457,968 100% Optimized S&M 100% $ 10,000,000

OPEX $ 6,940,504 107% 100% 65% $ 6,500,000

S&M $ 1,057,846 16% 15% Consolidated G&A 15% $ 1,500,000

G&A $ 1,259,312 20% 18% 15% $ 1,500,000

R&D $ 4,623,346 72% 67% 35% $ 3,500,000

Reduced R&D Spend

Loss $ (482,536) -7% 35% $ 3,500,000

29 TSX.V V H I
Comparable Companies

$33M $9.35 5.5x $322M $54.20 4.5x $224M $37.02 12.7x

2.4B $739.0 6.5x $66M $16.25 3.2x $333M $66.75 6.3x

30 Revenue* Share Price Revenue multiple TSX.V V H I

Recent Transaction – QHR: Canadian EMR Company (TSX.V)

QHR Operations
$30M

$20M

$10M

$M
2013 2014 2015 Sale

Revenue Net (loss) earnings

QHR recently announced its sale to Loblaws

for $170M – 5x multiple of revenue

Note: This transaction is in no way indicative of transactions currently available to or contemplated by the Corporation. The economics for the transaction presented in this slide, including the revenue
multiples and historical trading prices, are not typical and there can be no guarantee that the Corporation will be able to complete a similar transaction or any transaction at all.

31 TSX.V V H I
VitalHub Inc. – Summary

• TSX.V listed Healthcare IT company creating innovative Blockchain technology platform

• Proven management team and board with strong track record, ability to execute, and
public markets experience
• Focused M&A strategy positioned for rapid growth, with 15 potential acquisition
targets identified (profitable “hedge” strategy, providing real downside protection)
• Offshore R&D strategy that cuts costs, increases margins, improves efficiency; and enables
the scalability, growth, and development of Blockchain solutions
32 TSX.V V H I
Statutory rights for subscribers resident in Ontario and Saskatchewan: (1/2)

Section 130.1 of the Securities Act (Ontario) (the “Ontario Act”) and Section 138 of the Securities Act
(Saskatchewan) (the “Saskatchewan Act”) provides that every purchaser of securities pursuant to an offering memorandum shall have a statutory right
of action for damages or rescission against the issuer and any selling security holder in the event that the offering memorandum contains any untrue
statement of a material fact or omits to contain a material fact that is required or that is necessary in order to make any statement herein or therein not
misleading in the light of the circumstances in which it was made (a “Misrepresentation”). A purchaser who purchases securities offered by the offering
memorandum during the period of distribution has, without regard to whether the purchaser relied upon the Misrepresentation, a right of action for
damages or, alternatively, while still the owner of the securities, for rescission against the issuer and any selling security holder provided that:
a) if the purchaser exercises its right of rescission, it shall cease to have a right of action for damages as against the issuer and the selling security
holders, if any;
b) the issuer and the selling security holders, if any, will not be liable if they prove that the purchaser purchased the securities with knowledge of the
Misrepresentation;
c) the issuer and the selling security holders, if any, will not be liable for all or any portion of damages that it proves do not represent the depreciation
in value of the securities as a result of the Misrepresentation relied upon; and
d) in no case shall the amount recoverable exceed the price at which the securities were offered.

Section 138 of the Ontario Act, and Section 147 of the Saskatchewan Act provide that no action shall be commenced to enforce these rights more
than:
a) in the case of an action for rescission, 180 days from the day of the transaction that gave rise to the cause of action; or
b) in the case of an action for damages, the earlier of:
I. 180 days from the day that the purchaser first had knowledge of the facts giving rise to the cause of action; or
II. three years from the day of the transaction that gave rise to the cause of action.

33 TSX.V V H I
Statutory rights for subscribers resident in Ontario and Saskatchewan: (2/2)

The rights referred to in section 130.1 of the Securities Act (Ontario) do not apply in respect of an offering memorandum delivered to a prospective
purchaser in connection with a distribution made in reliance on the exemption from the prospectus requirement in section 2.3 of National Instrument
45-106 (the “accredited investor” exemption) if the prospective purchaser is:

a) a Canadian financial institution or a Schedule Ill bank,

b) the Business Development Bank of Canada incorporated under the Business Development Bank
of Canada Act (Canada), or
c) a subsidiary of any person referred to in paragraphs (a) and (b), if the person owns all of the voting securities of the subsidiary, except the voting
securities required by law to be owned by directors of that subsidiary.

Pursuant to Section 80.1(3) of the Saskatchewan Act, a purchaser who has received an amended offering memorandum delivered in accordance with
subsection 80.1(3) of the Saskatchewan Act has a right to withdraw from the agreement to purchase the securities by delivering a notice to the
person who or company that is selling the securities, indicating the purchaser’s intention not to be bound by the purchase agreement, provided such
notice is delivered by the purchaser within two business days of receiving the amended offering memorandum.
Similar rights of rescission are available to subscribers resident in Alberta pursuant to the provisions of Section 204 of the Securities Act (Alberta).
Subscribers in Alberta are advised to consult the Securities Act (Alberta) for the specific language pertaining to their rights.

34 TSX.V V H I
Appendix I: Future Adoption of Blockchain in Healthcare

Which solution/improvement has the most potential to drive Blockchain adoption

across the Healthcare industry?

Interoperability of Electronic Health

42.9%
Public Data Use cases (Provider Directory)
7.1%
Claims

17.9% Other
28.6%
Eligibility
3.5%

35 (Source: January 2017 Hyperledger Healthcare Working Group Survey, N=28 TSX.V V H I
Appendix II: 6 Big Themes for Blockchain Technology in Healthcare

Health Data Interoperability
Provide ubiquitous security
infrastructure for seamless
health data exchange without
reconciliation or trusted
3rd party.
Healthcare Business Models
Transform the digital health
economy to create new business
and monetization models
for health asset
exchange.
Cybersecurity
Distributed network consensus
with cryptography techniques
provides an additional layer of
trust to minimize cybersecurity
threats for healthcare IT
systems.

“Blockchain technology
potential applications Value-Based Care
in some of the pressing Trusted workflows with
“single source of truth” provide
Healthcare Consumerism Precision Medicine Practice
Patients can permit access to
Ensure co-creation of trust and
needs of the radical new possibilities for
self- sovereignty for a patient-
their anonymized personal
outcome-based care health information for research
Healthcare industry.” delivery and reimbursement
centric Blockchain health
ecosystem.
commons and remunerative
models. models.

36 (Source: "Blockchain Technology in Global Healthcare, 2017–2025", Frost & Sullivan, June 2017.) TSX.V V H I
Appendix III: Adoption Timeline – Blockchain Healthcare Use Cases

Blockchain Technology Adoption Timeline Across Major Healthcare Applications/Use Cases, Global, 2016–2025
Immediate (2016–2018) Short-Term future (2018-2021) Long-Term future (2021-2025)
Digital Identity Verification/ IoMT (medical asset management IoMT
Management and device data exchange) (Quantified self, home care)

National Medical/ Health Smart Contracts (health vendors Universal Health Records
Records (authenticity and integrity) RFPs and contract management) and Identities

Drug Supply Chain Provenance (drug Health Token (HSN, research, Genomics and User-generated Data
counterfeiting and theft) wellness incentives) Management

Claims Adjudication & Billing Managing Pharma/Biopharma IP and Assets Transactions Blockchain AI and AR/VR
Management/ RCM on Blockchain Applications

eConsenting Clinical Trials Records Blockchain-based Wellness,

(Research and clinical trials) Integrity and Exchange Personal Coaching

Healthcare Data Storage, Access, Regulatory Audit and Adverse Event Health Policy Voting
and Analytics (on/off Blockchain) Safety Monitoring

Note: Blockchain system adoption across these healthcare use cases demonstrate more convincing opportunities, albeit at Blockchain-based Learning Health
varying degrees of adoption across countries and health systems. Systems and Advocates

Certainty of Adoption High Medium Low

37 (Source: "Blockchain Technology in Global Healthcare, 2017–2025", Frost & Sullivan, June 2017.) TSX.V V H I
Appendix IV: Use Case 2 – Claims Adjudication & Billing Management

About 6% of all medical claims are denied due to incomplete or incorrect information. The Blockchain
system could automate the claim process and dispel administration layers to reduce transaction costs
and frauds.

Insurance notarization and medical billing frauds: An estimated 5%–10% of health care costs are fraudulent,
Challenges

resulting from excessive billing or billing for non-performed services. For example, in the United States alone, a
Current

Medicare fraud scheme incurred about $30 million in losses during 2016.
Inefficiencies with BIR activities: An estimated 15%–20% of health care spending and processing costs are
associated with BIR activities. E.g., US BIR costs are projected to reach $315 billion dollars by 2018, up over
100% from 2007.

Key Blockchain Features

Automates claim adjudication and payment processing.
Blockchain network consensus custody log to track each step of trustless exchange with predefined smart contracts.
Peer-to-peer insurance: Peer-evaluated and peer-adjudicated health claims.
Pay for outcomes and incentive-based behavioral health programs, leveraging smart contracting features.

38 (Source: "Blockchain Technology in Global Healthcare, 2017–2025", Frost & Sullivan, June 2017.) TSX.V V H I
Appendix IV: Use Case 2 – Claims Adjudication & Billing Management

(i) An estimated 5-10% of healthcare costs are fraudulent, resulting from excessive billing
or billing for non-performed services.

(ii) Blockchain-based systems can provide realistic solutions for minimizing these medical
billing-related frauds; by automating the majority of claim adjudication and payment
processing activities, Blockchain systems could help to eliminate the need for
intermediaries and reduce the administrative costs and time for providers and payers.

(iii) Recently, Gem Health, a provider of Blockchain application platforms

for enterprises, has collaborated with Capital One to develop
Blockchain-based healthcare claims management solutions.

39 (Source: "Does Blockchain Have A Place In Healthcare?" Forbes, www.forbes.com, May 8, 2017.) TSX.V V H I